Literature DB >> 2706416

Outcome from multiple joint replacement surgery to the lower limbs.

D J Walker1, K Usher, M O'Morchoe, L Sandles, I D Griffiths, I M Pinder.   

Abstract

All patients who had three or more major joints (hips or knees) replaced were identified from operation records at one hospital and reviewed to assess outcome. Forty-three were found to suffer from rheumatoid arthritis, four from osteoarthritis and three from psoriatic arthritis. Eight patients had died an average of 2.6 years (range 1-7 years) after their last operation and this was higher than expected, even for RA. Average follow-up in the 36 surviving RA sufferers was 1.8 years, with a minimum of 6 months since last operation. Range of joint movement, pain relief, satisfaction, mobility, disability and social outcomes were assessed and are reported. Patients were satisfied with outcome because of pain relief and functional improvement. No patient required permanent in-patient care, although they still represented a very disabled group with mean HAQ score of 2.75.

Entities:  

Mesh:

Year:  1989        PMID: 2706416     DOI: 10.1093/rheumatology/28.2.139

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  3 in total

1.  Functional Evaluation of Patients Undergoing Multiple Joint Replacements: A Retrospective Study of 50 Patients with a Minimum of Six Months of Follow-up.

Authors:  Shubhranshu S Mohanty; Nandan Mishra; Prateek Patil; Ajinkya Desale
Journal:  Cureus       Date:  2016-10-15

2.  [Surgical planning and mid-term effectiveness of four major lower extremity arthroplasties in patients with rheumatoid arthritis].

Authors:  Bangjie Sun; Chengkai Zhang; Hong Chen; Liying Wang; Yongshi Li; Yi Zeng; Jing Yang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2022-05-15

3.  Outcomes for patients undergoing one or more total hip and knee arthroplasties.

Authors:  Y Kageyama; S Miyamoto; T Ozeki; M Hiyoshi; K Kushida; T Inoue
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.